Sam Boughedda

Becton, Dickinson and Company announced Monday it had reached a deal to buy Parata Systems, which is a supplier of pharmacy automation solutions, from Frazier Healthcare Partners for $1.525 million.

BD, a company in medical technology, stated that all cash transactions are expected to be completed by the close of the first quarter of BD’s fiscal 2023. It will expand its offerings to include new automation solutions for pharmacies.

“Parata expands BD’s solutions to a new area of the high-growth pharmacy automation space and is a prime example of BD executing our disciplined M&A strategy,” said Tom Polen, chairman, chief executive officer and president of BD. “Parata is an attractive company with a strong value proposition and a financial profile that meets all our investment criteria regarding growth, profitability, returns and sustainability.”

Rick Wise, Stifel Analyst, stated that BD had been focusing on its 2025 strategy for some time. This was based in part on shedding low-growth assets like diabetes care, and shifting towards more transformative, faster-growing solutions.

The analyst stated that they viewed this transaction “as another positive step forward” in their multi-faceted BD Transformation.